You are here

  • Home
  • Archive
  • Volume 7, Issue 4
  • Rofecoxib, 25 mg/day, was more effective than rofecoxib, 12.5 mg/day, celecoxib, or acetaminophen in osteoarthritis of the knee

Article Text

Article menu
Download PDFPDF
Therapeutics
Rofecoxib, 25 mg/day, was more effective than rofecoxib, 12.5 mg/day, celecoxib, or acetaminophen in osteoarthritis of the knee

https://doi.org/10.1136/ebm.7.4.123

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Source of funding: Merck & Co, Inc.

    • For correspondence: Dr G P Geba, Merck & Co Inc, West Point, Philadelphia, USA. gregory_geba{at}merck.com.

    • ↵* See glossary.

    • ↵† Information provided by author.